Is Planet Labs Stock a Buy or Sell After Its Co-Founder Sold Shares Worth $1.4 Million?

Planet Labs Co‑Founder and CSO Robert H. Schingler executed an open‑market sale of 73,782 directly‑held shares on Dec. 26, 2025 for approximately $1.43 million at a weighted average price of $19.35, reducing his direct holdings to 834,558 shares and transferring 330,171 shares to Ulysses Trust 02021.1; his direct stake has declined ~36.78% since September 2024. The trade was run under a Rule 10b5‑1 plan and coincides with a sharp stock rally (1‑year +414.11%, 52‑week high $20.99); fundamentals show improving revenue (TTM $282.46m; fiscal Q3 revenue $81.3m) and narrower operating losses, suggesting limited market disruption and that the sale aligns with prior insider selling cadence rather than a change in company outlook.

Analysis

Market structure: The insider sale (73,782 shares ≈ $1.43M) is immaterial to market liquidity — ~0.023% of a $6.17B market cap — but the pattern (36.8% decline in direct holdings since Sep‑2024 and transfers into Ulysses Trust) reduces future incremental insider supply and signals personal liquidity/estate planning rather than negative info. Demand drivers are stronger: record Q3 revenue $81.3M (+33% YoY) and new government contracts support recurring revenue, but the market has priced much of that upside (P/S ≈22). Net: modest short‑term supply relief but stretched valuation increases sensitivity to execution risk.

Risk assessment: Tail risks include loss or non-renewal of key government contracts, a satellite failure causing data interruptions, or a capital‑ markets dislocation that forces equity dilution (each could cause >40% downside). In the next days–weeks, price is vulnerable to profit taking; over 3–12 months, fundamentals matter — sustained ARR growth <25% or margins not improving would compress multiples back toward P/S 8–12. Hidden dependency: revenue is concentrated in a few government customers and cloud/processing costs scale with constellation size; margin inflection is the critical second‑order variable.

Trade implications: Preferred tactical stance is wait for a disciplined pullback (target $13–15, ~30–35% correction) to establish size; otherwise use option overlays for asymmetric exposure. Use 3–6 month put spreads to cap downside while selling near‑term calls to monetize elevated IV; consider a relative value pair vs Maxar (MAXR) if you favor lower multiple cashflow names over growth symbolism. Rebalance sector exposure into larger, cash‑positive geospatial/defense contractors if ARR or margin inflection points slip.

Contrarian angles: Consensus treats the sale as neutral and the stock as richly priced; what’s missing is that Planet’s high revisit cadence and platform lock‑in can justify premium multiples if net retention >110% and gross margins rise to >60% by mid‑2026. The market may underprice the stickiness of enterprise/government subs; conversely, the current P/S implies near‑perfect execution — any slippage is punished. Historical parallels: high‑growth SaaS/space names rerated higher on durable contract wins but suffered 30–60% drawdowns on execution misses; positioning should reflect both outcomes.

Key Decisions for Investors

• Consider establishing a 2–3% portfolio long position in Planet Labs (PL) only on a pullback to $13–15 (≈P/S 12–15); set tactical target $28 by Dec‑2026 and a strict stop at 25% below entry to limit downside if ARR or margins disappoint.
• If long PL today, sell 30–60 day covered calls at the $22–24 strikes to harvest premium, and simultaneously purchase a 3‑month put spread (buy $15 put / sell $10 put) sized to protect 50–70% of position value — cost‑limited hedge for event risk through the next two earnings cycles.
• Implement a 6–12 month pair trade: short PL and go long Maxar Technologies (MAXR) dollar‑neutral (size to match beta) when PL trades above P/S 20 and MAXR trades at materially lower multiple; target 20–40% spread compression or outperformance of MAXR by 6–12 months.
• Reduce aggregate exposure to small‑cap Earth‑observation/growth satellite names by 20–30% over the next 30 days and redeploy into larger, cash‑positive defense/geospatial providers if Planet fails to show margin improvement or ARR growth >30% at the next quarterly report (expected by Feb–Mar 2026).